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Background
Systemic Lupus Erythematosus (SLE) patients often
exhibit signs and symptoms of cardiac ischemia with an
overall increased prevalence of coronary artery disease
(CAD), coronary microvascular dysfunction and myocar-
ditis in this population. Potentially, these processes may
be associated with subclinical changes in myocardial tis-
sue. Elevated native myocardial T1 and extracellular
volume (ECV), measures of myocardial fibrosis, have
previously been shown in asymptomatic SLE patients,
implying subclinical myocardial disease. We assessed the
hypothesis that native myocardial T1 and ECV would be
abnormally elevated in SLE subjects with chest pain.
Methods
We evaluated 13 women with SLE and with current or
prior history of chest pain and no obstructive coronary
disease and 11 matched normal controls using T1 map-
ping at 1.5T (Siemens Avanto). Native T1 maps were
acquired in a single mid-ventricular slice with a 5(3)3
MOLLI sequence; post-contrast T1 maps were acquired in
the same slice 10-15 minutes after contrast injection with
a 4(1)3(1)2 MOLLI sequence. Healthy controls had a nor-
mal exercise stress test and no history of cardiovascular
disease.
Results
The healthy control group (n = 11) and SLE group (n =
13) were well matched in age (50.5 ± 10.4 vs 46.4 ± 11,
p = 0.374) and BMI (25.9 ± 4.5 vs 26.0 ± 7.6, p = 0.357).
Eight SLE subjects had current or past corticosteroid use
and 7 had current or past use of a cytotoxic agent. Seven
SLE subjects had current chest pain while 6 were with-
out. Average SLE duration was 19.5 years. Native myo-
cardial T1 values were increased in the women with SLE
with current or past chest pain compared to reference
control women (1049.4 ± 34.4 vs 1003.2 ± 19.3 ms, p =
0.005) (Figure). ECV values were elevated compared to
published values for normal controls using the same T1
mapping sequences at 1.5T (27.2 ± 3.6 vs 25.4 ± 2.5%).
Native T1 values were increased in SLE subjects with
current chest pain symptoms compared to those without,
however not significantly (1056.3 ± 31.1 vs 1041.5 ± 31.1,
p = 0.46). No significant difference in ECV was observed
between SLE subjects with and without current chest
pain symptoms. No significant relationship was shown
between native myocardial T1 or ECV and age, BMI, dis-
ease duration, or SLEDAI (SLE Disease Activity Index).
However, native myocardial T1 trended toward posi-
tive correlation with corticosteroid use (r = 0.507, p =
0.077) as well as the use of cytotoxic agents (r = 0.495,
p = 0.086).
Conclusions
Among women with SLE, chest pain, and no obstructive
coronary disease, native myocardial T1 measured by
CMR is elevated consistent with diffuse fibrosis com-
pared to controls. Further work will validate the pre-
sence of diffuse fibrosis with native T1 and ECV in
women with SLE, chest pain, and no obstructive CAD.
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Figure 1 Native myocardial T1 in SLE subjects with chest pain
versus healthy controls (1003.2 ± 19.3 vs 1049.4 ± 34.4 ms,
p = 0.005).
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